Controlling cardiac transport and plaque formation

Ze'ev Aronis1, Sagi Raz, Elisha J P Martinez

  • 1Department of Biomedical Engineering, Tel Aviv University, Tel Aviv 69978, Israel.

Insights

Atherosclerotic plaque rupture is influenced by blood flow dynamics. A severe distal plaque can create forces that destabilize an adjacent, less severe plaque, increasing rupture risk.

Area of Science:

  • Cardiovascular science
  • Biomedical engineering
  • Hemodynamics

Background:

  • Atherosclerosis involves LDL particle and macrophage infiltration into artery walls.
  • Blood flow patterns, particularly low shear stress and high oscillations, influence LDL infiltration and plaque development.
  • Plaque rupture often occurs near the minimum lumen area, prompting investigation into the role of adjacent plaques.

Purpose of the Study:

  • To investigate the hemodynamic forces generated by a severe distal atherosclerotic plaque.
  • To determine if these forces can destabilize a proximal, non-stenotic plaque and promote rupture.

Main Methods:

  • Developed physical models of coronary artery stenoses (single and double).
  • Utilized continuous Doppler particle image velocimetry (CDPIV) to analyze blood flow between stenoses.
  • Measured hydrostatic pressure acting on the proximal plaque.

Main Results:

  • A significant distal stenosis created disturbed blood flow with high shear rates and oscillatory patterns.
  • These hemodynamic conditions, combined with high hydrostatic pressure, increased LDL and macrophage uptake in the proximal plaque.
  • The disturbed flow enriched the lipid core, and high pressure induced stresses that can trigger plaque rupture.

Conclusions:

  • Hemodynamic forces from a severe distal stenosis can destabilize a proximal plaque.
  • This interaction promotes plaque vulnerability by enhancing lipid accumulation and internal stress.
  • Understanding these mechanics is crucial for predicting and preventing atherosclerotic plaque rupture.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...